Technology

HER-2 Targeted Drugs for Breast Cancer Market – Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of HER-2 Targeted Drugs for Breast Cancer in Global, including the following market information:

  • Global HER-2 Targeted Drugs for Breast Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)

 

The global HER-2 Targeted Drugs for Breast Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trastuzumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HER-2 Targeted Drugs for Breast Cancer include Roche, Chugai Pharmaceutical, GlaxoSmithKline, Novartis, Pfizer, CANbridge, Puma Biotechnology, Hengrui Medicine and Beacon Pharmaceuticals Limited and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the HER-2 Targeted Drugs for Breast Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HER-2 Targeted Drugs for Breast Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HER-2 Targeted Drugs for Breast Cancer Market Segment Percentages, by Type, 2021 (%)

  • Trastuzumab
  • Pertuzumab
  • Lapatinib
  • Neratinib
  • Trastuzumab Emtansine
  • Pyrotinib
  • Other

Global HER-2 Targeted Drugs for Breast Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HER-2 Targeted Drugs for Breast Cancer Market Segment Percentages, by Application, 2021 (%)

  • Hospital
  • Clinic
  • Drug Center
  • Other

Global HER-2 Targeted Drugs for Breast Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HER-2 Targeted Drugs for Breast Cancer Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies HER-2 Targeted Drugs for Breast Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies HER-2 Targeted Drugs for Breast Cancer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Roche
  • Chugai Pharmaceutical
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • CANbridge
  • Puma Biotechnology
  • Hengrui Medicine
  • Beacon Pharmaceuticals Limited
  • Hetero Drugs

Table of content

1 Introduction to Research & Analysis Reports
1.1 HER-2 Targeted Drugs for Breast Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HER-2 Targeted Drugs for Breast Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HER-2 Targeted Drugs for Breast Cancer Overall Market Size
2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size: 2021 VS 2028
2.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HER-2 Targeted Drugs for Breast Cancer Players in Global Market
3.2 Top Global HER-2 Targeted Drugs for Breast Cancer Companies Ranked by Revenue
3.3 Global HER-2 Targeted Drugs for Breast Cancer Revenue by Companies
3.4 Top 3 and Top 5 HER-2 Targeted Drugs for Breast Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies HER-2 Targeted Drugs for Breast Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 HER-2 Targeted Drugs for Breast Cancer Players in Global Market

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Targeted Drugs for Breast Cancer Market – Global Outlook and Forecast 2022-2028

ER Targeted Drugs for Breast Cancer Market – Global Outlook and Forecast 2022-2028

VEGF Targeted Drugs for Breast Cancer Market – Global Outlook and Forecast 2022-2028

Global and Japan Targeted Drugs for Breast Cancer Market Size, Status and Forecast 2021-2027

Related Articles

Back to top button